Gene · 831
Papers2,076
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,076
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WNK3 inhibition elicits antitumor immunity by suppressing PD-L1 expression on tumor cells and activating T-cell function. | Exp Mol Med | 2022 | 36357569 | PubTator, text mining | PubMed |
| Promotion of a synthetic degradation of activated STAT6 by PARP-1 inhibition: roles of poly(ADP-ribosyl)ation, calpains and autophagy. | J Transl Med | 2022 | 36348405 | PubTator, text mining | PubMed |
| The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer. | Sci Rep | 2022 | 36344556 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Monkeypox infection: The past, present, and future. | Int Immunopharmacol | 2022 | 36330915 | PubTator, text mining | PubMed |
| Cosbin: cosine score-based iterative normalization of biologically diverse samples. | Bioinform Adv | 2022 | 36330358 | PubTator, text mining | PubMed |
| Estimating the Similarity between Protein Pockets. | Int J Mol Sci | 2022 | 36293316 | PubTator, text mining | PubMed |
| Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells. | Biomolecules | 2022 | 36291610 | PubTator, text mining | PubMed |
| Identifying cancer cell-secreted proteins that activate cancer-associated fibroblasts as prognostic factors for patients with pancreatic cancer. | J Cell Mol Med | 2022 | 36282889 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| Preclinical model for phenotypic correction of dystrophic epidermolysis bullosa by in vivo CRISPR-Cas9 delivery using adenoviral vectors. | Mol Ther Methods Clin Dev | 2022 | 36212909 | PubTator, text mining | PubMed |
| RNA-seq profiling reveals different pathways between remodeled vessels and myocardium in hypertrophic cardiomyopathy. | Microcirculation | 2022 | 36198058 | PubTator, text mining | PubMed |
| New insights into the mechanism of freeze-induced damage based on ice crystal morphology and exudate proteomics. | Food Res Int | 2022 | 36192927 | PubTator, text mining | PubMed |
| A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19. | Comput Struct Biotechnol J | 2022 | 36187929 | PubTator, text mining | PubMed |
| Structure of the TnsB transposase-DNA complex of type V-K CRISPR-associated transposon. | Nat Commun | 2022 | 36184667 | PubTator, text mining | PubMed |
| Mitochondrial oxidative stress contributes to diastolic dysfunction through impaired mitochondrial dynamics. | Redox Biol | 2022 | 36183542 | PubTator, text mining | PubMed |
| Molecular mechanisms of synaptogenesis. | Front Synaptic Neurosci | 2022 | 36176941 | PubTator, text mining | PubMed |
| Targeting SARS-CoV-2 Main Protease for Treatment of COVID-19: Covalent Inhibitors Structure-Activity Relationship Insights and Evolution Perspectives. | J Med Chem | 2022 | 36169610 | PubTator, text mining | PubMed |
| Deep multilayer brain omics identifies the potential involvement of menopause molecular networks in Gliomas' disease progression. | FASEB J | 2022 | 36165217 | PubTator, text mining | PubMed |
| Mitochondrial Dysfunction in Spinal Muscular Atrophy. | Int J Mol Sci | 2022 | 36142791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/831/papers?page=14